Pharmamarketeer
wet- en regelgeving

Retrophin receives US FDA approval for Thiola EC 100mg & 300mg tablets to treat cystinuria

1 augustus 2019
Pharma Biz

Retrophin, Inc., announced that the US Food and Drug Administration (FDA) has approved 100 mg and 300 mg tablets of Thiola EC (tiopronin), a new enteric─coated formulation of Thiola (tiopronin)

Ook interessant voor je

Medhc-fases-banner
Advertentie(s)